https://www.selleckchem.com/products/Tubacin.html
95% (15/252) in the treatment group and control group, respectively. Protective ileostomy did not show a significant advantage in reducing the incidence of postoperative anastomotic leakage in patients with rectal cancer, and it may lead to a permanent stoma. Protective ileostomy did not show a significant advantage in reducing the incidence of postoperative anastomotic leakage in patients with rectal cancer, and it may lead to a permanent stoma. Several agents are being developed for advanced HER2-positive breast cancer, such as potent
Like
Comment
Share
